Achilles therapeutics to present at upcoming conferences

London, april 05, 2022 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing precision t cell therapies to treat solid tumors, today announced that management will be taking part in the following conferences in april.

ACHL Ratings Summary

ACHL Quant Ranking